Mississauga, Ontario plant tapped to produce mRNA for Moderna’s COVID-19 vaccines | The Canadian News

Under a new multi-year agreement, a plant in Mississauga, Ontario. Moderna has chosen to manufacture a key ingredient needed for its global supply of COVID-19 vaccines.

According to a declaration, The National Resilience Incorporated facility will be responsible for providing messenger RNA (mRNA) substances for use by the vaccine manufacturer.

“This collaboration has the potential to ensure that more people around the world are protected from the deadly COVID-19 virus,” wrote Rahul Singhvi, CEO of Resilience.

The news came months after the federal government announced that it would provide nearly $ 200 million to the company to help ensure that mRNA vaccines are made in Canada.

The announcement also came nearly a month after Moderna signed a memorandum of understanding with the federal government to build a state-of-the-art mRNA vaccine manufacturing plant somewhere in Canada, which will mark the first facility based outside the United States. Company presence in the United States.

Global News contacted Moderna on Thursday morning to request an update on the project, but did not receive a response at the time of publication.

The lack of national vaccine manufacturing capacity came to the fore during the COVID-19 pandemic, as the Canadian government had to compete with other countries for doses from plants located around the world.

The mRNA acts as a blueprint for human cells, it triggers the creation of a specific protein found in a virus.

When it comes to the SARS-CoV-2 (COVID-19) virus, a spike protein is created and ultimately, after an injection, a person’s immune system must recognize it and develop antibodies to fight the virus.

Experts praised the versatility of the new mRNA technology and how it can be used to help fight other viruses and diseases.

– With files from Jamie Mauracher

See link »